Q32 Bio (QTTB) EBIT (QoQ) (2017 - 2026)
Q32 Bio (QTTB) EBIT (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Q32 Bio | 215.66 Mn | 164.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.83% |
| Dec 31, 2025 | 705.50% |
| Sep 30, 2025 | 17.38% |
| Jun 30, 2025 | 25.00% |
| Mar 31, 2025 | 15.82% |
| Dec 31, 2024 | 22.79% |
| Sep 30, 2024 | -4.99% |
| Jun 30, 2024 | -20.72% |
| Mar 31, 2024 | 42.49% |
| Dec 31, 2023 | -230.97% |
| Sep 30, 2023 | -7.19% |
| Jun 30, 2023 | 1.33% |
| Mar 31, 2023 | 78.63% |
| Dec 31, 2022 | -4.97% |
| Sep 30, 2022 | -16.09% |
| Jun 30, 2022 | 24.75% |
| Mar 31, 2022 | -11.88% |
| Dec 31, 2021 | -9.67% |
| Sep 30, 2021 | -0.36% |
| Jun 30, 2021 | -2,649.95% |